Complete financial analysis of 10X Capital Venture Acquisition Corp. III (VCXB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 10X Capital Venture Acquisition Corp. III, a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Investcorp India Acquisition Corp (IVCAW) Income Statement Analysis – Financial Results
- Vestum AB (publ) (VESTUM.ST) Income Statement Analysis – Financial Results
- Winshine Science Company Limited (0209.HK) Income Statement Analysis – Financial Results
- AMIN TANNERY LIMITED (AMINTAN.BO) Income Statement Analysis – Financial Results
- Sincere Navigation Corporation (2605.TW) Income Statement Analysis – Financial Results
10X Capital Venture Acquisition Corp. III (VCXB)
About 10X Capital Venture Acquisition Corp. III
10X Capital Venture Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to identify business opportunities in the field of consumer internet, e-commerce, software, healthcare, transportation/mobility, financial services, artificial intelligence, automation, data science, and Software-as-a-Service. The company was incorporated in 2021 and is based in New York, New York.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 3.46M | 44.61K |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 3.46M | 44.61K |
| Other Expenses | 0.00 | 0.00 |
| Operating Expenses | 3.46M | 44.61K |
| Cost & Expenses | 3.46M | 44.61K |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 |
| Depreciation & Amortization | -4.16M | 236.56K |
| EBITDA | -7.62M | -44.61K |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -3.46M | -44.61K |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 4.16M | 0.00 |
| Income Before Tax | 698.29K | -44.61K |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | -4.16M | -48.66K |
| Net Income | 4.86M | -44.61K |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.02 | 0.00 |
| EPS Diluted | 0.02 | 0.00 |
| Weighted Avg Shares Out | 40.00M | 41.15M |
| Weighted Avg Shares Out (Dil) | 40.00M | 41.15M |
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of 10X Capital Venture Acquisition Corp. III (VCXB WS)
NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of 10X Capital Venture Acquisition Corp. III (the “Company”), each whole warrant exercisable...
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing
New York, NY, April 23, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated April 17, 2024 (the “Notice”), notified 10X III...
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance
New York, NY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB, VCXB.U, VCXB WS) (“10X III”), announced today that NYSE Regulation (“NYSER”), by letter dated January 29, 2024 (the “Notice”), notified 10X III...
10X Capital Venture Acquisition Corp. III Announces Expected Change in Management
NEW YORK, NY (United States), Jan. 08, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE American:VCXB), a publicly traded special purpose acquisition company, announced today that, subject to approval by the board of directors, it...
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing
New York, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today that New York Stock Exchange Regulation, Inc., by letter dated November 21, 2023 (the “Notice”), notified 10X III...
10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American
New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U, VCXB, VCXB WS) (“10X III”) today announced that it is transferring the listing of its Class A ordinary shares, par value $0.0001 per...
Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III
NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 09, 2023 (GLOBE NEWSWIRE) -- NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 9, 2023 (GLOBE NEWSWIRE) – American Gene Technologies International Inc. (“AGT”) and 10X Capital Venture Acquisition Corp....
Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 09, 2023 (GLOBE NEWSWIRE) -- NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 9, 2023 (GLOBE NEWSWIRE) – American Gene Technologies International Inc. (“AGT”) and 10X Capital Venture Acquisition Corp....
Source: https://incomestatements.info
Category: Stock Reports